Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for Induction and Maintenance in Ulcerative Colitis (ULTRA 2)
NCT00408629Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 2006
- Primary completion
- Mar 2010
- Modality
- Monoclonal Antibodies
- Countries
- 18
01
Overview
A Phase 3 trial of adalimumab in ulcerative colitis (UC), sponsored by Abbott Laboratories. Started Nov 2006; status: completed.
02
Drugs
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00408629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408629.